Free tool
FDA Clearance Tracker
Last checked: Nov 19, 2026Latest source record: Nov 8, 2026 (newest decision)openFDA last updated: Nov 9, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Product code QKA: Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia. Open this device type's page
4 decisions
product code QKA. Showing 1 to 4, newest first. PMA results are original approvals and panel-track supplements.
K261342 · Decided Jun 22, 2026 · 60 days after receipt
Device type: Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia (QKA) · GI, Urology & Nephrology
K253525 · Decided Mar 12, 2026 · 119 days after receipt
Device type: Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia (QKA) · GI, Urology & Nephrology
- iTind System510(k)
K210138 · Decided Jun 25, 2021 · 157 days after receipt
Device type: Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia (QKA) · GI, Urology & Nephrology
- iTind SystemNew device typeDe Novo
DEN190020 · Decided Feb 25, 2020 · 329 days after receipt
Device type: Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia (QKA) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.